- $5.48bn
- $4.46bn
- $4.04m
U.S. STOCKS ON THE MOVE-Gold miners, Tesla, ADM
U.S. STOCKS ON THE MOVE-Candel Therapeutics, Broadcom, Reddit
U.S. STOCKS ON THE MOVE-Exxon Mobil, Mondelez International, Macy's
U.S. STOCKS ON THE MOVE-General Motors, GE Vernova, Amazon
CG Oncology falls after unveiling stock offering
Brief: CG Oncology Files For Offering Of Up To 7.3 Mln Shares Of Common Stock
Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer
Brief: CG Oncology Announces 74.5% Complete Response In Phase 3 Trial
Biotech IPOs signal recovery following 2-year slump, GlobalData says
Brief: CG Oncology Announces First Patient Dosed In PIVOT-006 Phase 3 Clinical Trial Of Cretostimogene In Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Fractyl Health prices US IPO below range to raise $110 mln
Kyverna Therapeutics targets up to $711 mln valuation in US IPO
CG Oncology valued at $1.75 bln in strong market debut (updated)
CG Oncology valued at $1.75 bln in strong market debut
Brief: CG Oncology Announces Pricing Of Upsized Initial Public Offering